URSA-PHARM-R06: Patients with Priority Adherence Medication
  • 27 Apr 2023
  • 1 Minute to read
  • Dark
    Light

URSA-PHARM-R06: Patients with Priority Adherence Medication

  • Dark
    Light

Article summary

Measure Description

Includes patient periods of active plan membership during which the patient has one or more active Priority Adherence Medication including; (1) Antidepressants, (2) Antineoplastic, (3) Antidiabetics, (4) Betablockers, (5) Oral ACEI/ARBs, or (6) Statins

Metadata

  • Measure Type: Registry
  • Temporal Structure: Entity
  • Component Class: Normal-Form
  • Denominator Case Field: Patient ID
  • Target Direction: None

None.

FAQs

None.


Was this article helpful?